New drug trial offers hope for rare liver disease
NCT ID NCT05896137
Summary
This study is testing an experimental drug called CS0159 for people with Primary Sclerosing Cholangitis (PSC), a rare disease that scars the bile ducts in the liver. The main goal is to see if the drug is safe and if it can lower a key liver enzyme (ALP) over 12 weeks. The trial will involve about 50 adult patients in China, who will be randomly assigned to receive either the drug or a placebo for the first part, followed by a longer open-label period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SCLEROSING CHOLANGITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Friendship Hospital, Captail Medcial University
Beijing, Beijing Municipality, 100050, China
-
Beijing YouAn Hostital, Captial Medical University
Beijing, Beijing Municipality, 100069, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
-
Qilu Hospital of Shandong University
Jinan, Shandong, China
-
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200120, China
-
Shaoyifu Hospital of Zhejiang University Medical
Hangzhou, Zhejiang, 310000, China
-
The First Affiliated Hospital of USTC Anhui Provincial Hospital
Hefei, Anhui, China
-
The First Affiliated Hospital,Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
The First Bethune Hospital of Jilin University
Changchun, Jilin, China
-
The Seconed Xiangya Hospital of Central South University
Changsha, Hunan, 410011, China
-
Wuhan Union Hospital of China
Wuhan, Hubei, 430022, China
Conditions
Explore the condition pages connected to this study.